Skip to main content

Press Releases and Ad-hoc Announcements

29 April 2026	PR: Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026	PDF
17 April 2026	PR: Heidelberg Pharma Announces Change in Executive Board	PDF
09 April 2026	AH: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101	PDF
04 April 2026	PR: Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026	PDF
26 March 2026	PM: Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026	PDF
18 March 2026	PR: Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China	PDF
09 March 2026	PR: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital	PDF
07 March 2026	AH: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital	PDF
29 January 2026	PR: Heidelberg Pharma Received Development Milestone Payment from Partner Takeda	PDF